{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:10:58Z","timestamp":1788649858266,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05274-z","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:30:52Z","timestamp":1783769452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Research progress and trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric and visualization analysis (1990s to post-COVID-19 era)"],"prefix":"10.1038","author":[{"given":"Jing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"5274_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain, S. et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 372, 835\u2013845 (2015).","journal-title":"N. Engl. J. Med."},{"key":"5274_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00651-24","volume":"12","author":"B Chen","year":"2024","unstructured":"Chen, B. et al. The epidemic characteristics of Mycoplasma pneumoniae infection among children in Anhui, China, 2015\u20132023. Microbiol. Spectr. 12, e0065124 (2024).","journal-title":"Microbiol. Spectr."},{"key":"5274_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","volume":"20","author":"C Yan","year":"2024","unstructured":"Yan, C. et al. Current status of Mycoplasma pneumoniae infection in China. World J. Pediatr. 20, 1\u20134 (2024).","journal-title":"World J. Pediatr."},{"key":"5274_CR4","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.lanmic.2024.101019","volume":"6","author":"ESGMAC MAPS study group","year":"2025","unstructured":"ESGMAC MAPS study group Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study. Lancet Microbe 6, 101019 (2025).","journal-title":"Lancet Microbe"},{"key":"5274_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites, K. B., Xiao, L., Liu, Y., Balish, M. F. & Atkinson, T. P. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin. Microbiol. Rev. 30, 747\u2013809 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"5274_CR6","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim, K. et al. Global trends in the proportion of Macrolide-Resistant Mycoplasma pneumoniae infections: a systematic review and Meta-analysis. JAMA Netw. Open 5, e2220949 (2022).","journal-title":"JAMA Netw. Open"},{"key":"5274_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3201\/eid2607.200017","volume":"26","author":"YC Chen","year":"2020","unstructured":"Chen, Y. C., Hsu, W. Y. & Chang, T. H. Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia. Emerg. Infect. Dis. 26, 1382\u20131391 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"5274_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cid\/ciy419","volume":"68","author":"PK Kutty","year":"2019","unstructured":"Kutty, P. K. et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin. Infect. Dis. 68, 5\u201312 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"5274_CR9","doi-asserted-by":"publisher","first-page":"e215840","DOI":"10.1001\/jamanetworkopen.2021.5840","volume":"4","author":"M Wilson","year":"2021","unstructured":"Wilson, M., Sampson, M., Barrowman, N. & Doja, A. Bibliometric analysis of neurology articles published in general medicine journals. JAMA Netw. Open 4, e215840 (2021).","journal-title":"JAMA Netw. Open"},{"key":"5274_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa044080","volume":"354","author":"SL Johnston","year":"2006","unstructured":"Johnston, S. L. et al. The effect of telithromycin in acute exacerbations of asthma. N. Engl. J. Med. 354, 1589\u20131600 (2006).","journal-title":"N. Engl. J. Med."},{"key":"5274_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2500\/aap.2009.30.3207","volume":"30","author":"TP Atkinson","year":"2009","unstructured":"Atkinson, T. P., Duffy, L. B., Pendley, D., Dai, Y. & Cassell, G. H. Deficient immune response to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc. 30, 158\u2013165 (2009).","journal-title":"Allergy Asthma Proc."},{"key":"5274_CR12","first-page":"557","volume":"54","author":"TA Tsai","year":"2021","unstructured":"Tsai, T. A., Tsai, C. K., Kuo, K. C. & Yu, H. R. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J. Microbiol. Immunol. 54, 557\u2013565 (2021).","journal-title":"J. Microbiol. Immunol."},{"key":"5274_CR13","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000839","volume":"147","author":"LW Gao","year":"2019","unstructured":"Gao, L. W. et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol. Infect. 147, e192 (2019).","journal-title":"Epidemiol. Infect."},{"key":"5274_CR14","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2666-5247(23)00344-0","volume":"5","author":"PM Meyer Sauteur","year":"2024","unstructured":"Meyer Sauteur, P. M. et al. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe 5, e100\u2013e101 (2024).","journal-title":"Lancet Microbe"},{"key":"5274_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","volume":"16","author":"H Lee","year":"2018","unstructured":"Lee, H., Yun, K. W., Lee, H. J. & Choi, E. H. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev. Anti Infect. Ther. 16, 23\u201334 (2018).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"5274_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","volume":"120","author":"KL Lee","year":"2021","unstructured":"Lee, K. L. et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010\u20132019. J. Formos. Med. Assoc. 120, 281\u2013291 (2021).","journal-title":"J. Formos. Med. Assoc."},{"key":"5274_CR17","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/jcm11102824","volume":"11","author":"L Tong","year":"2022","unstructured":"Tong, L., Huang, S., Zheng, C., Zhang, Y. & Chen, Z. Refractory Mycoplasma pneumoniae pneumonia in children: early recognition and management. J. Clin. Med. 11, 2824 (2022).","journal-title":"J. Clin. Med."},{"key":"5274_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00405-6","volume":"5","author":"H Li","year":"2024","unstructured":"Li, H., Li, S., Yang, H., Chen, Z. & Zhou, Z. Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China. Lancet Microbe 5, e515 (2024).","journal-title":"Lancet Microbe"},{"key":"5274_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","volume":"25","author":"G Li","year":"2019","unstructured":"Li, G. et al. High co-expression of TNF-alpha and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia. Mol. Med. 25, 38 (2019).","journal-title":"Mol. Med."},{"key":"5274_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1183\/09031936.01.17202410","volume":"17","author":"S Esposito","year":"2001","unstructured":"Esposito, S. et al. Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group. Eur. Respir. J. 17, 241\u2013245 (2001).","journal-title":"Eur. Respir. J."},{"key":"5274_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijantimicag.2011.01.008","volume":"37","author":"S Esposito","year":"2011","unstructured":"Esposito, S., Tagliabue, C., Bosis, S. & Principi, N. N. Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood. Int. J. Antimicrob. Agents 37, 472\u2013475 (2011).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"5274_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3201\/eid2310.170106","volume":"23","author":"T Tanaka","year":"2017","unstructured":"Tanaka, T. et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008\u20132015. Emerg. Infect. Dis. 23, 1703\u20131706 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"5274_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03245-20","volume":"59","author":"T Kakiuchi","year":"2021","unstructured":"Kakiuchi, T. et al. Clinical evaluation of a novel point-of-care assay to detect Mycoplasma pneumoniae and associated macrolide-resistant mutations. J. Clin. Microbiol. 59, e0324520 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"5274_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/asi.22968","volume":"65","author":"C Chen","year":"2014","unstructured":"Chen, C. & Leydesdorff, L. Patterns of connections and movements in dual-map overlays: a new method of publication portfolio analysis. J. Assoc. Inf. Sci. Technol. 65, 334\u2013351 (2014).","journal-title":"J. Assoc. Inf. Sci. Technol."},{"key":"5274_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25120-6","volume":"12","author":"ZJ Li","year":"2021","unstructured":"Li, Z. J. et al. Etiological and epidemiological features of acute respiratory infections in China. Nat. Commun. 12, 5026 (2021).","journal-title":"Nat. Commun."},{"key":"5274_CR26","first-page":"256","volume":"86","author":"X Li","year":"2023","unstructured":"Li, X., Li, T., Chen, N., Kang, P. & Yang, J. Changes of Mycoplasma pneumoniae prevalence in children before and after COVID-19 pandemic in Henan, China. J. Infect. 86, 256\u2013308 (2023).","journal-title":"J. Infect."},{"key":"5274_CR27","doi-asserted-by":"publisher","first-page":"1424554","DOI":"10.3389\/fcimb.2024.1424554","volume":"14","author":"J You","year":"2024","unstructured":"You, J. et al. Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China. Front. Cell. Infect. Microbiol. 14, 1424554 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"5274_CR28","first-page":"2100746","volume":"27","author":"PMM Sauteur","year":"2022","unstructured":"Sauteur, P. M. M. et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Eur. Surveill. 27, 2100746 (2022).","journal-title":"Eur. Surveill."},{"key":"5274_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00182-9","volume":"4","author":"PM Meyer Sauteur","year":"2023","unstructured":"Meyer Sauteur, P. M. et al. Mycoplasma pneumoniae: gone forever? Lancet Microbe 4, e763 (2023).","journal-title":"Lancet Microbe"},{"key":"5274_CR30","first-page":"3","volume":"53","author":"R Burrell","year":"2025","unstructured":"Burrell, R., Saravanos, G. & Britton, P. N. Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections. Paediatr. Respir. Rev. 53, 3\u201313 (2025).","journal-title":"Paediatr. Respir. Rev."},{"key":"5274_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S1473-3099(23)00200-1","volume":"23","author":"A Izu","year":"2023","unstructured":"Izu, A. et al. All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020\u201322) compared with the pre-pandemic period (2015\u201319) in South Africa: an observational study. Lancet Infect. Dis. 23, 1031\u20131041 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"5274_CR32","unstructured":"World Health Organization (WHO). Disease Outbreak News. Upsurge of respiratory illnesses among children in northern China. Accessed November 23, 2023. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON494"},{"key":"5274_CR33","doi-asserted-by":"publisher","first-page":"e70092","DOI":"10.1111\/apm.70092","volume":"133","author":"R Liu","year":"2025","unstructured":"Liu, R., Shao, W. & Ye, Q. Resurgence of Mycoplasma pneumoniae infections in the post-COVID-19 era: epidemiology, therapeutic challenges, and mitigation strategies. Apmis 133, e70092 (2025).","journal-title":"Apmis"},{"key":"5274_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.pathol.2025.03.002","volume":"57","author":"S Baumgart","year":"2025","unstructured":"Baumgart, S. et al. Mycoplasma pneumoniae: evolving diagnostic methods for a known pathogen. Pathology 57, 415\u2013424 (2025).","journal-title":"Pathology"},{"key":"5274_CR35","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10096-010-0975-2","volume":"29","author":"K Loens","year":"2010","unstructured":"Loens, K., Goossens, H. & Ieven, M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur. J. Clin. Microbiol. Infect. Dis. 29, 1055\u20131069 (2010).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"5274_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jmii.2018.09.001","volume":"53","author":"LJ Lin","year":"2020","unstructured":"Lin, L. J. et al. The diagnostic value of serological studies in pediatric patients with acute Mycoplasma pneumoniae infection. J. Microbiol. Immunol. Infect. 53, 351\u2013356 (2020).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"5274_CR37","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1128\/JCM.02048-14","volume":"52","author":"R Dumke","year":"2014","unstructured":"Dumke, R., Jacobs, E. & Patel, R. Evaluation of five real-time PCR assays for detection of Mycoplasma pneumoniae. J. Clin. Microbiol. 52, 4078\u20134081 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"5274_CR38","first-page":"270","volume":"134","author":"L Zhang","year":"2011","unstructured":"Zhang, L., Zong, Z. Y., Liu, Y. B., Ye, H. & Lv, X. J. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J. Med. Res. 134, 270\u2013280 (2011).","journal-title":"Indian J. Med. Res."},{"key":"5274_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104868","volume":"98","author":"MH Koenen","year":"2023","unstructured":"Koenen, M. H. et al. Mycoplasma pneumoniae carriage in children with recurrent respiratory tract infections is associated with a less diverse and altered microbiota. eBioMedicine 98, 104868 (2023).","journal-title":"eBioMedicine"},{"key":"5274_CR40","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1164\/rccm.201904-0860LE","volume":"200","author":"PM Meyer Sauteur","year":"2019","unstructured":"Meyer Sauteur, P. M. et al. Diagnosis of Mycoplasma pneumoniae pneumonia with measurement of specific antibody-secreting cells. Am. J. Respir. Crit. Care Med. 200, 1066\u20131069 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"5274_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55932-9","volume":"16","author":"S Viz-Lasheras","year":"2025","unstructured":"Viz-Lasheras, S. et al. A Diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment. Nat. Commun. 16, 673 (2025).","journal-title":"Nat. Commun."},{"key":"5274_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-019-0576-5","volume":"8","author":"F Zhao","year":"2019","unstructured":"Zhao, F. et al. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China. Antimicrob. Resist. Infect. Control 8, 143 (2019).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"5274_CR43","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3201\/eid2408.180081","volume":"24","author":"JK Lee","year":"2018","unstructured":"Lee, J. K. et al. Clonal expansion of macrolide-resistant sequence type 3 Mycoplasma pneumoniae, South Korea. Emerg. Infect. Dis. 24, 1465\u20131471 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"5274_CR44","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3201\/eid2609.191575","volume":"26","author":"M Morozumi","year":"2020","unstructured":"Morozumi, M. et al. Sequence type changes associated with decreasing macrolide-resistant Mycoplasma pneumoniae, Japan. Emerg. Infect. Dis. 26, 2210\u20132213 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"5274_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fmicb.2016.00232","volume":"7","author":"MH Diaz","year":"2016","unstructured":"Diaz, M. H. & Winchell, J. M. The Evolution of advanced molecular diagnostics for the detection and characterization of Mycoplasma pneumoniae. Front. Microbiol. 7, 232 (2016).","journal-title":"Front. Microbiol."},{"key":"5274_CR46","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/JCM.01935-08","volume":"47","author":"S De\u0301grange","year":"2009","unstructured":"De\u0301grange, S. et al. Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J. Clin. Microbiol. 47, 914\u2013923 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"5274_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nmni.2015.05.005","volume":"7","author":"VJ Chalker","year":"2015","unstructured":"Chalker, V. J. et al. International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. N. Microbes N. Infect. 7, 37\u201340 (2015).","journal-title":"N. Microbes N. Infect."},{"key":"5274_CR48","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/jac\/dkac170","volume":"77","author":"G Wang","year":"2022","unstructured":"Wang, G., Wu, P., Tang, R. & Zhang, W. Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis. J. Antimicrob. Chemother. 77, 2353\u20132363 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"5274_CR49","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/S2666-5247(24)00086-7","volume":"5","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Li, X., Fu, Y., Yu, Y. & Zhou, H. Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China. Lancet Microbe 5, 100870 (2024).","journal-title":"Lancet Microbe"},{"key":"5274_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2026.2614742","volume":"15","author":"X Zhu","year":"2026","unstructured":"Zhu, X. et al. Global molecular epidemiology of Mycoplasma pneumoniae and its association with macrolide resistance and disease severity: a systematic review and meta-analysis. Emerg. Microbes Infect. 15, 2614742 (2026).","journal-title":"Emerg. Microbes Infect."},{"key":"5274_CR51","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1097\/INF.0000000000005019","volume":"44","author":"K Ouchi","year":"2025","unstructured":"Ouchi, K. & Oishi, T. Recent global trends of macrolide-resistant Mycoplasma pneumoniae: why has the macrolide-resistant rate decreased in Japan? Pediatr. Infect. Dis. J. 44, e446\u2013e449 (2025).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"5274_CR52","doi-asserted-by":"publisher","first-page":"102589","DOI":"10.1016\/j.eclinm.2024.102589","volume":"71","author":"F Cai","year":"2024","unstructured":"Cai, F., Li, J., Liang, W., Wang, L. & Ruan, J. Effectiveness and safety of tetracyclines and quinolones in people with Mycoplasma pneumonia: a systematic review and network meta-analysis. EClinicalMedicine 71, 102589 (2024).","journal-title":"EClinicalMedicine"},{"key":"5274_CR53","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","volume":"60","author":"A Lu","year":"2015","unstructured":"Lu, A., Wang, C., Zhang, X., Wang, L. & Qian, L. Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children. Respir. Care 60, 1469\u20131475 (2015).","journal-title":"Respir. Care"},{"key":"5274_CR54","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12931-024-02892-1","volume":"25","author":"D Wei","year":"2024","unstructured":"Wei, D., Zhao, Y., Zhang, T., Xu, Y. & Guo, W. The role of LDH and ferritin levels as biomarkers for corticosteroid dosage in children with refractory Mycoplasma pneumoniae pneumonia. Respir. Res. 25, 266 (2024).","journal-title":"Respir. Res."},{"key":"5274_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2353298","volume":"13","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China. Emerg. Microbes Infect. 13, 2353298 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"5274_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29602","volume":"96","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: a retrospective study. J. Med. Virol. 96, e29602 (2024).","journal-title":"J. Med. Virol."},{"key":"5274_CR57","first-page":"1840","volume":"13","author":"DH Lee","year":"2023","unstructured":"Lee, D. H., Choi, Y. J., Kim, J., Han, E. & Bae, M. H. Pre-pandemic distribution of bacterial species in nasopharyngeal swab specimens from pediatric and adult patients detected via RT-PCR using the allplex respiratory panel. Life (Basel) 13, 1840 (2023).","journal-title":"Life (Basel)"},{"key":"5274_CR58","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s15010-025-02482-3","volume":"53","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Panoramic quantitative and visualization-based bibliometric analysis of Mycoplasma pneumoniae. Infection 53, 1699\u20131713 (2025).","journal-title":"Infection"},{"key":"5274_CR59","doi-asserted-by":"publisher","first-page":"e37521","DOI":"10.1097\/MD.0000000000037521","volume":"103","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Research status and challenges of Mycoplasma pneumoniae pneumonia in children: a bibliometric and visualization analysis from 2011 to 2023. Med. (Baltim.) 103, e37521 (2024).","journal-title":"Med. (Baltim.)"},{"key":"5274_CR60","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/nar\/24.22.4420","volume":"24","author":"R Himmelreich","year":"1996","unstructured":"Himmelreich, R. et al. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res 24, 4420\u20134449 (1996).","journal-title":"Nucleic Acids Res"},{"key":"5274_CR61","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1093\/nar\/28.17.3278","volume":"28","author":"T Dandekar","year":"2000","unstructured":"Dandekar, T. et al. Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res. 28, 3278\u20133288 (2000).","journal-title":"Nucleic Acids Res."},{"key":"5274_CR62","doi-asserted-by":"publisher","first-page":"e1005299","DOI":"10.1371\/journal.ppat.1005299","volume":"11","author":"D Nakane","year":"2015","unstructured":"Nakane, D., Kenri, T., Matsuo, L. & Miyata, M. Systematic structural analyses of attachment organelle in Mycoplasma pneumoniae. PLoS Pathog. 11, e1005299 (2015).","journal-title":"PLoS Pathog."},{"key":"5274_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18777-y","volume":"11","author":"D Vizarraga","year":"2020","unstructured":"Vizarraga, D. et al. Immunodominant proteins P1 and P40\/P90 from human pathogen Mycoplasma pneumoniae. Nat. Commun. 11, 5188 (2020).","journal-title":"Nat. Commun."},{"key":"5274_CR64","doi-asserted-by":"publisher","first-page":"e02186","DOI":"10.1128\/mBio.02186-14","volume":"5","author":"S Bose","year":"2014","unstructured":"Bose, S. et al. ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity. mBio 5, e02186\u201314 (2014).","journal-title":"mBio"},{"key":"5274_CR65","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1073\/pnas.1420308112","volume":"112","author":"A Becker","year":"2015","unstructured":"Becker, A. et al. Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proc. Natl. Acad. Sci. USA 112, 5165\u20135170 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5274_CR66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/pathogens10020119","volume":"10","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z., Li, S., Zhu, C., Zhou, R. & Leung, P. H. M. Mycoplasma pneumoniae Infections: pathogenesis and Vaccine Development. Pathogens 10, 119 (2021).","journal-title":"Pathogens"},{"key":"5274_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00011-026-02198-6","volume":"75","author":"HX Xiang","year":"2026","unstructured":"Xiang, H. X. et al. Host immune dysfunction and Mycoplasma pneumoniae immune evasion: dual drivers of pathogenesis in Mycoplasma pneumoniae pneumonia. Inflamm. Res. 75, 45 (2026).","journal-title":"Inflamm. Res."},{"key":"5274_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.mattod.2026.103188","volume":"93","author":"HW Zu","year":"2026","unstructured":"Zu, H. W. et al. A mucosal mRNA-LNP vaccine platform for broad-spectrum protection against Mycoplasma pneumoniae. Mater. Today 93, 103188 (2026).","journal-title":"Mater. Today"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05274-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:02:10Z","timestamp":1788649330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05274-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":68,"alternative-id":["5274"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05274-z","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}